Rosetta Genomics moved higher after it said it planned to offer up to $35 million in ordinary shares. The molecular-diagnostics company looks to raise money for its operations.
HB Fuller jumped after the specialty chemicals maker raised its full year profit forecast.
Supernus Pharmaceuticals soared after the FDA gave tentative approval for its epilepsy drug. The small cap company has a market cap of $280 million.
Questions? Comments? Email us at firstname.lastname@example.orgPage 2 of 2 | Prev Page